Search

everythinglearnresearchcommunity

for

Search:↓

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Emotional factors are crucial in treating and preventing scalp neurodermatitis and hair loss.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.